Inflammation and immune response in acute aortic dissection

Annals of Medicine

Volumn 42, Issue 8, 2010, Pages 622-629

  Del Porto, Flavia ^a   Proietta, Maria ^a   Tritapepe, Luigi ^b   Miraldi, Fabio ^c   Koverech, Angela ^a   Cardelli, Patrizia ^d   Tabacco, Fabio ^d   De Santis, Vincenzo ^b   Vecchione, Andrea ^a   Mitterhofer, Anna Paola ^c   Nofroni, Italo ^c   Amodeo, Rachele ^d   Trappolini, Massimo ^a   Aliberti, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Dipartimento Scienze Anestesiologiche   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

^d II Facolt di Medicina e Chirurgia   (Italy)

Author keywords

Aortic dissection; cytokiness; lymphocyte; subpopulations

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AORTA DISSECTION; AORTA WALL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; ANEURYSM, DISSECTING; AORTIC DISEASES; CYTOKINES; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 78249273251     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.518156     Document Type: Article

References (37)

1. Tsai TT, Nienaber CH, Eagle KA. Acute aortic syndromes. Circulation. 2005;112:3802-13.
2. Ramanath VS, Stundt TM, Eagle KA. Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clin Proc. 2009;84: 465-81.
3. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The international registry of acute aortic dissection (IRAD) New insights into an old disease. JAMA. 2000;283:897-903.
4. Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111:816-28.
5. Luo F, Zhou XL, LI JJ, Hui RT. Infl ammatory response is associated with aortic dissection. Ageing Res Rev. 2009;8: 31-5.
6. Shimizu K, Richard NM, Libby P. Infl ammation and cellular immune responses in abdominal aortic aneurysms. Arterio-scler Thromb Vasc Biol. 2006;26:987-94.
7. He R, Guo DG, Estrera AL, Safi HJ, Huynh TT, Yin Z, et al. Characterization of the infl ammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. 2006; 131:671-8.
8. Weis-Muller BT, Modlich O, Drobinskaya I, Unay D, Huber R, Bojar H, et al. Gene expression in acute Stanford type A dissection: a comparative microarray study. J Transl Med. 2006; 4:29-44.
9. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneu-rysm. Lancet. 2005;365:1577-89.
10. Manabe T, Imoto K, Uchida K, Doi C, Takanashi Y. Decreased tissue inhibitor of metalloproteinase-2/matrix met-alloproteinases ratio in the acute phase of aortic dissection. Surg Today. 2004;34:220-5.
11. Koullias GJ, Korkolis DP, Ravichandran P, Psyrri A, Hatzaras I, Elefteriades JA. Increased tissue microarray matrix metal-loproteinase expresion favors proteolysis in thoracic aortic aneurysms and dissections. Eur J Cardiothorac Surg. 2004;26: 1098-103.
12. Lindholt JS, Shi GP. Chronic infl ammation, immune response, and infection in abdominal aortic, aneurysms. Eur J Vasc Endovasc Surg. 2006;31:453-63.
13. Patel MI, Melrose J, Ghosh P, Appleberg M. Increased synthesis of matrix metalloproteinases by aortic smooth cells is implicated in the etiopathogenesis of abdominal aortic aneu-rysms. J Vasc Surg. 1996;24:82-92.
14. Newman KM, Claude JC, Li H, Ramey WG, Tilson MD. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 1994;90:224-7.
15. Yamamoto T, Eckes B, Mauch C, Hartmann K, Krieg T. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fi broblasts by an autocrine IL-1 α loop. J Immunol. 2000;164: 6174-9.
16. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med. 2005;352:1685-95.
17. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in infl ammation. N Engl J Med. 2006;354:610-21.
18. Wagner A, Domanovits H, Holzer M, Kofler J, Röggla M, Müllner M, et al. Plasma endothelin in patients with acute aortic disease. Resuscitation. 2002;53:71-6.
19. Schonbeck U, Sukhova GK, Gerdes N, Libby P. Th2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol. 2002;161:499-506.
20. Schulte S, Sukhova GK, Libby P. Genetically programmed biases in Th1 and Th2 immune responses modulates athero-genesis. Am J Pathol. 2008;172:1500-8.
21. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, et al. The complex role of T-cell based immunity in atherosclerosis. Curr Atheroscler Rep. 2008;10:236-43.
22. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802-15.
23. Xu C, Zarins CK, Glagov S. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg. 2001;33:91-6.
24. Lindeman JH, Abdul-Hussein H, Schaapherder AF, Van Bockel JH, Von der Thusen JH, Roelen DL, et al. Enhanced expression and activation of pro-infl ammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6 and IL-8-dominated infl ammatory responses prevail in the human aneurysm. Clin Sci (Lond). 2008;114:687-97.
25. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-defi cient mice. Arterioscler Thromb Vasc Biol. 2003;23:1621-6.
26. Gredmark-Russ S, Dzabixc M, Rahbar A, Wanhainen A, Bjorck M, Larsson E, et al. Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm. J Mol Med. 2009;87:347-56.
27. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;102: 2883-8.
28. Ocana E, Bohorquez JC, Perez-Requena J, Brieva JA, Rodríguez C. Characterization of T and B lymphocytes infi l-trating abdominal aortic aneurysms. Atherosclerosis. 2003; 170:39-48.
29. Dugast AS, Vanhove B. Immune regulation by non-lymphoid cells in transplantation. Clin Exp Immunol. 2009;156:25-34.
30. O'Garra A, Vierra P. Regulatory T cells and mechanisms of immune system control. Nat Med. 2004;10:801-5.
31. Horkko S, Miller E, Branch DW, Palinski W, Witztum JL. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipids and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci USA. 1997;24: 10356-61.
32. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, et al. Oxidation-specifi c epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest. 2009;119:1335-49.
33. Eliason JL, Hannawa KK, Ailawadi G, Sinha I, Ford JW, Deogracias MP, et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation. 2005;112:232-40.
34. Forester ND, Cruickshank SM, Scott DJA, Carding SR. Increased natural killer cell activity in patients with an abdominal aortic aneurysm. Br J Surg. 2006;93:46-54.
35. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751-62.
36. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) fi nal report. Circulation. 2002. 106; 3143-421.
37. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation. Geneva: World Health Organization; 2006.